Capitolis Advisors’s Qiagen QGEN Stock Holding History

Capitolis Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-118,600	Closed	-$6.99M	–	416
2021 Q4	$6.99M	Buy	118,600 +57,982	+96%	+$3.32M	0.04%	276
2021 Q3	$3.35M	Buy	+60,618	New	+$3.38M	0.03%	260

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Capitolis Advisors's QGEN Position: Q1 2022 in Review

Capitolis Advisors sold out of Qiagen (QGEN) in Q1 2022, closing a stake of 118,600 shares — an estimated $6.99M sold.

Capitolis Advisors first reported a position in QGEN in Q3 2021 and held it in 2 quarters. The position peaked at $6.99M in Q4 2021. 292 funds tracked by Wall St. Rank hold QGEN as of Q1 2022.

Capitolis Advisors reported no remaining Qiagen position as of Q1 2022 after selling out during the quarter.
Capitolis Advisors sold 118,600 Qiagen shares in Q1 2022, an estimated $6.99M.
Capitolis Advisors first reported a position in Qiagen in Q3 2021 and held it in 2 quarters.
Capitolis Advisors's Qiagen position peaked at $6.99M in Q4 2021.
292 funds tracked by Wall St. Rank held Qiagen as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.